Compass Therapeutics Inc. (CMPX) NASDAQ
$1.51 0.02 (1.34%)
Market Cap: $205.01M
As of 04/23/24 03:59 PM EDT. Market closed.
Compass Therapeutics Inc. (CMPX)
NASDAQ
$1.51
0.02 (1.34%)
Market Cap: $205.01M
As of 04/23/24 03:59 PM EDT. Market closed.
Add to Portfolio
compass therapeutics is an antibody discovery and development company focused on comprehensively drugging the tumor-immune synapse with combinations of human monoclonal antibodies, multiclonals, and engineered protein constructs. compass is industrializing antibody discovery and decentralizing biologic validation through a partnership-first mentality that leverages best-in-class technologies and ... read more
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
35
URL
Address
.
PRICE CHART FOR COMPASS THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.52
Previous Close
$1.49
Days Range
$1.44 - $1.54
52 week range
$1.15 - $3.62
Volume
72,067
Avg. Volume (30 days)
358,489
Market Cap
$205.01M
Dividend Yield
-
P/E
-
Shares Outstanding
137,589,171
Open
$1.52
Previous Close
$1.49
Days Range
$1.44 - $1.54
52 week range
$1.15 - $3.62
Volume
72,067
Avg. Volume (30 days)
358,489
Market Cap
$205.01M
Dividend Yield
-
P/E
-
Shares Outstanding
137,589,171
FINANCIAL STATEMENTS FOR COMPASS THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR COMPASS THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | Feb 08, 2024 | Option Exercise | $1.45 | 49,198 | 71,337 | 3,124,426 | Feb 09, 2024, 12:50 PM |
| Schuetz Thomas J. | PRESIDENT | Feb 08, 2024 | Option Exercise | $1.45 | 44,782 | 64,934 | 6,570,566 | Feb 09, 2024, 12:49 PM |
| Bisker-Leib Vered | Chief Executive Officer | Jan 09, 2024 | Option Exercise | $1.93 | 1,753,125 | 3,383,531 | 3,173,624 | Jan 10, 2024, 10:31 AM |
| Schuetz Thomas J. | President of R&D | Jan 09, 2024 | Option Exercise | $1.93 | 637,500 | 1,230,375 | 6,615,348 | Jan 10, 2024, 10:31 AM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 17, 2023 | Option Exercise | $1.50 | 64,415 | 96,623 | 1,420,499 | Nov 21, 2023, 02:10 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Nov 17, 2023 | Option Exercise | $1.50 | 44,025 | 66,038 | 5,977,848 | Nov 21, 2023, 02:08 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Mar 10, 2023 | Buy | $3.37 | 10,000 | 33,700 | 6,021,873 | Mar 10, 2023, 01:34 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Feb 27, 2023 | Buy | $3.98 | 20,000 | 79,600 | 6,011,873 | Feb 27, 2023, 11:39 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Feb 15, 2023 | Buy | $3.86 | 20,000 | 77,200 | 5,991,873 | Feb 15, 2023, 10:47 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jan 31, 2023 | Buy | $4.05 | 20,000 | 81,000 | 5,471,873 | Jan 31, 2023, 10:14 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jan 24, 2023 | Buy | $4.19 | 20,000 | 83,800 | 5,451,873 | Jan 24, 2023, 10:49 AM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 25, 2022 | Sale | $4.36 | 2 | 9 | 1,060,414 | Nov 25, 2022, 04:41 PM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 23, 2022 | Sale | $4.30 | 9,569 | 41,147 | 1,060,416 | Nov 25, 2022, 04:41 PM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 22, 2022 | Sale | $4.19 | 14,929 | 62,553 | 1,069,985 | Nov 25, 2022, 04:41 PM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 21, 2022 | Sale | $4.34 | 16,035 | 69,592 | 1,084,914 | Nov 22, 2022, 04:15 PM |
| Bisker-Leib Vered | Chief Operating Officer | Nov 18, 2022 | Sale | $4.40 | 6,226 | 27,394 | 1,107,175 | Nov 22, 2022, 04:15 PM |
| ORBIMED ADVISORS LLC | Director | Nov 08, 2022 | Buy | $3.21 | 402,000 | 1,290,420 | 15,219,994 | Nov 10, 2022, 04:44 PM |
| GORDON CARL L | Director | Nov 08, 2022 | Buy | $3.21 | 402,000 | 1,290,420 | 15,219,994 | Nov 10, 2022, 04:38 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sep 28, 2022 | Buy | $2.32 | 10,000 | 23,200 | 5,431,873 | Sep 28, 2022, 04:45 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sep 26, 2022 | Buy | $2.27 | 15,000 | 34,050 | 5,421,873 | Sep 27, 2022, 09:47 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sep 07, 2022 | Buy | $3.03 | 15,000 | 45,450 | 5,406,873 | Sep 08, 2022, 10:12 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Sep 01, 2022 | Buy | $2.83 | 15,000 | 42,450 | 5,391,873 | Sep 01, 2022, 02:37 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Aug 10, 2022 | Buy | $2.64 | 15,000 | 39,600 | 5,361,873 | Aug 10, 2022, 10:51 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Aug 01, 2022 | Buy | $2.58 | 15,000 | 38,700 | 5,346,873 | Aug 02, 2022, 09:15 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jun 21, 2022 | Buy | $2.80 | 20,000 | 56,000 | 5,331,873 | Jun 21, 2022, 01:41 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jun 16, 2022 | Buy | $2.34 | 20,000 | 46,800 | 5,311,873 | Jun 17, 2022, 04:46 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jun 13, 2022 | Buy | $2.29 | 30,000 | 68,700 | 5,291,873 | Jun 13, 2022, 03:59 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jun 06, 2022 | Buy | $2.83 | 30,000 | 84,900 | 5,261,873 | Jun 07, 2022, 11:50 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | Jun 01, 2022 | Buy | $3.03 | 20,000 | 60,600 | 5,231,873 | Jun 01, 2022, 12:33 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | May 26, 2022 | Buy | $3.04 | 20,000 | 60,800 | 5,211,873 | May 26, 2022, 02:58 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | May 23, 2022 | Buy | $2.72 | 18,355 | 49,926 | 5,191,873 | May 24, 2022, 08:09 AM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | May 17, 2022 | Buy | $2.47 | 20,215 | 49,931 | 5,173,518 | May 17, 2022, 03:17 PM |
| GORDON CARL L | Director | May 13, 2022 | Buy | $2.49 | 30,722 | 76,498 | 14,817,994 | May 13, 2022, 05:48 PM |
| GORDON CARL L | Director | May 12, 2022 | Buy | $2.35 | 97,094 | 228,171 | 14,787,272 | May 13, 2022, 05:48 PM |
| GORDON CARL L | Director | May 11, 2022 | Buy | $1.79 | 64,700 | 115,813 | 14,690,178 | May 13, 2022, 05:48 PM |
| ORBIMED ADVISORS LLC | Director | May 12, 2022 | Buy | $2.35 | 97,094 | 228,171 | 14,787,272 | May 13, 2022, 05:45 PM |
| ORBIMED ADVISORS LLC | Director | May 11, 2022 | Buy | $1.79 | 64,700 | 115,813 | 14,690,178 | May 13, 2022, 05:45 PM |
| ORBIMED ADVISORS LLC | Director | May 13, 2022 | Buy | $2.49 | 30,722 | 76,498 | 14,817,994 | May 13, 2022, 05:45 PM |
| ORBIMED ADVISORS LLC | Director | May 09, 2022 | Buy | $1.56 | 90,712 | 141,511 | 14,601,031 | May 10, 2022, 06:21 PM |
| ORBIMED ADVISORS LLC | Director | May 06, 2022 | Buy | $1.63 | 10,200 | 16,626 | 14,510,319 | May 10, 2022, 06:21 PM |
| ORBIMED ADVISORS LLC | Director | May 10, 2022 | Buy | $1.60 | 24,447 | 39,115 | 14,625,478 | May 10, 2022, 06:21 PM |
| GORDON CARL L | Director | May 10, 2022 | Buy | $1.60 | 24,447 | 39,115 | 14,625,478 | May 10, 2022, 06:19 PM |
| GORDON CARL L | Director | May 09, 2022 | Buy | $1.56 | 90,712 | 141,511 | 14,601,031 | May 10, 2022, 06:19 PM |
| GORDON CARL L | Director | May 06, 2022 | Buy | $1.63 | 10,200 | 16,626 | 14,510,319 | May 10, 2022, 06:19 PM |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | May 10, 2022 | Buy | $1.80 | 27,836 | 50,105 | 5,153,303 | May 10, 2022, 02:15 PM |
| GORDON CARL L | Director | Nov 04, 2021 | Buy | $3.50 | 5,357,143 | 18,750,001 | 14,500,119 | Nov 08, 2021, 09:12 PM |
| ORBIMED ADVISORS LLC | Director | Nov 04, 2021 | Buy | $3.50 | 5,357,143 | 18,750,001 | 14,500,119 | Nov 08, 2021, 09:06 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Bisker-Leib Vered | CHIEF EXECUTIVE OFFICER | 02/08/2024 | 71,337 |
| Schuetz Thomas J. | PRESIDENT | 02/08/2024 | 64,934 |
| Bisker-Leib Vered | Chief Executive Officer | 01/09/2024 | 3,383,531 |
| Schuetz Thomas J. | President of R&D | 01/09/2024 | 1,230,375 |
| Bisker-Leib Vered | Chief Operating Officer | 11/17/2023 | 96,623 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 11/17/2023 | 66,038 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 03/10/2023 | 33,700 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 02/27/2023 | 79,600 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 02/15/2023 | 77,200 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 01/31/2023 | 81,000 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 01/24/2023 | 83,800 |
| Bisker-Leib Vered | Chief Operating Officer | 11/25/2022 | 9 |
| Bisker-Leib Vered | Chief Operating Officer | 11/23/2022 | 41,147 |
| Bisker-Leib Vered | Chief Operating Officer | 11/22/2022 | 62,553 |
| Bisker-Leib Vered | Chief Operating Officer | 11/21/2022 | 69,592 |
| Bisker-Leib Vered | Chief Operating Officer | 11/18/2022 | 27,394 |
| ORBIMED ADVISORS LLC | Director | 11/08/2022 | 1,290,420 |
| GORDON CARL L | Director | 11/08/2022 | 1,290,420 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 09/28/2022 | 23,200 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 09/26/2022 | 34,050 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 09/07/2022 | 45,450 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 09/01/2022 | 42,450 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 08/10/2022 | 39,600 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 08/01/2022 | 38,700 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 06/21/2022 | 56,000 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 06/16/2022 | 46,800 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 06/13/2022 | 68,700 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 06/06/2022 | 84,900 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 06/01/2022 | 60,600 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 05/26/2022 | 60,800 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 05/23/2022 | 49,926 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 05/17/2022 | 49,931 |
| GORDON CARL L | Director | 05/13/2022 | 76,498 |
| GORDON CARL L | Director | 05/12/2022 | 228,171 |
| GORDON CARL L | Director | 05/11/2022 | 115,813 |
| ORBIMED ADVISORS LLC | Director | 05/12/2022 | 228,171 |
| ORBIMED ADVISORS LLC | Director | 05/11/2022 | 115,813 |
| ORBIMED ADVISORS LLC | Director | 05/13/2022 | 76,498 |
| ORBIMED ADVISORS LLC | Director | 05/09/2022 | 141,511 |
| ORBIMED ADVISORS LLC | Director | 05/06/2022 | 16,626 |
| ORBIMED ADVISORS LLC | Director | 05/10/2022 | 39,115 |
| GORDON CARL L | Director | 05/10/2022 | 39,115 |
| GORDON CARL L | Director | 05/09/2022 | 141,511 |
| GORDON CARL L | Director | 05/06/2022 | 16,626 |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 05/10/2022 | 50,105 |
| GORDON CARL L | Director | 11/04/2021 | 18,750,001 |
| ORBIMED ADVISORS LLC | Director | 11/04/2021 | 18,750,001 |
Load More Insider Transactions
FUNDS WITH A POSITION IN COMPASS THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 18,791,422 | 0.84% | -15.97% | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 9,880,000 | 0.03% | 54.86% | Other |
| BLACKROCK INC. | 6,222,309 | 0.00025% | 4.16% | Other |
| BLACKSTONE INC. | 6,189,551 | 0.04% | No change | Other |
| VIVO CAPITAL, LLC | 3,556,023 | 0.55% | No change | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 1,992,028 | 0.00033% | 5.27% | Other |
| BAKER BROS. ADVISORS LP | 1,557,630 | 0.03% | No change | Other |
| RENAISSANCE TECHNOLOGIES LLC | 176,799 | 0.00043% | 559.7% | Other |
CHANGE IN SHARES OUTSTANDING FOR COMPASS THERAPEUTICS INC
STOCK BUYBACKS FOR COMPASS THERAPEUTICS INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.14%
1Q
06/30/2023
0.68%
2Q
03/31/2023
0.97%
3Q
12/31/2022
8.20%
4Q
09/30/2022
26.32%
5Q
06/30/2022
26.40%
6Q
03/31/2022
26.51%
7Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR COMPASS THERAPEUTICS INC
LOADING...